Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

MilfordMD Cosmetic Surgeon Dr. Richard E. Buckley Gives an Inside Look at "Skin Botox" - A Popular South Korean Treatment Gaining Popularity in the U.S.

"Skin Botox" or Botox Facial has been popular in South Korea for years but little-known in the U.S. Dr. Buckley discusses why the Aesthetic Society predicts "Skin Botox" to be a top trending cosmetic treatment in 2020.


News provided by

MilfordMD Cosmetic Dermatology Surgery & Laser Center

Mar 05, 2020, 02:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Richard E. Buckley of MilfordMD shares why Korean celebrities have sworn by ‘Skin Botox’ for years to achieve a smooth, airbrushed complexion and how it's gaining popularity in the U.S.
Dr. Richard E. Buckley of MilfordMD shares why Korean celebrities have sworn by ‘Skin Botox’ for years to achieve a smooth, airbrushed complexion and how it's gaining popularity in the U.S.

MILFORD, Pa., March 5, 2020 /PRNewswire-PRWeb/ -- Since 1999, Botox Cosmetic has been the number one aesthetic procedure performed by cosmetic surgeons. It's most well-known for treating facial lines and wrinkles, TMJ and migraines. Now the Aesthetic Society is predicting that a new use for Botox, known as Skin Botox, Botox Facial, Microtox, MesoBotox or Baby Botox is going to be a top trending cosmetic treatment in 2020 as more men and women are wanting to look their best, but not in an unnatural or "done" way.

"In Korea, where the ideal complexion is poreless and translucent, MesoBotox or 'Skin Botox' is the treatment Korean celebrities swear by to achieve the "glass skin" look and now MilfordMD is happy to be able to offer this fascinating treatment to our patients," says Dr. Richard E. Buckley, Cosmetic Surgeon and Medical Director of MilfordMD Cosmetic Dermatology Surgery & Laser Center. "At MilfordMD there has been an increase in patients requesting this treatment to smooth the skin and diminish fine wrinkles, especially among millennial men and women. Our commitment is to our patients, so we always strive to offer proven new procedures that deliver natural-looking results."

Patients are shifting away from wanting an overly done look, like the famous Kylie Jenner pout. Treatments like 'Skin Botox' are gaining in popularity because patients get a smoother, brighter complexion that still looks natural.

Post this

Trends are shifting away from overly-enhanced looks with 41% of patients stating a fear of looking unnatural as their top concern when considering cosmetic enhancements, as well as an influx in patients under 30 wanting cosmetic treatments according to the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) annual survey. "While South Korea has been using 'Skin Botox' for about 10 years, given the increasing demand for natural-looking results, especially from millennials, it's no surprise that the demand for Skin Botox in the U.S. is increasing," says Dr. Buckley.

"Traditional injections of botulinum toxin derivatives (neuromodulators), like Botox Cosmetic, Dysport, Jeuveau, and Xeomin are injected into the muscle bellies to decrease the muscular contraction. With microtox or 'Skin Botox', a diluted, small quantity of Botox, Dysport, Xeomin or Jeuveau and a hyaluronic acid filler, such as Restylane Refyne or Restylane Silk are very superficially injected into the skin where they only target the skin where oil production, facial flushing and acne occur," says Dr. Buckley. "The goal is to create particular changes in the face, such as helping to improve very fine wrinkles, decrease the production of oil, shrink pore size, and get a smoother appearance to the surface of the skin."

Traditional uses of neuromodulators (e.g. Dysport and Botox) iron out and prevent deep wrinkles in the skin by reducing muscle activity in specific areas of the face, such as the forehead, laugh lines or crow's feet. 'Skin Botox' is most frequently used to target pores to create an all-over smoothing effect.

"In order to achieve the smoothing effect, the Botox and hyaluronic acid need to be placed very superficially under the skin. At MilfordMD, the ultra-fine microneedling AQUAGOLD® fine touch™ device is the preferred method for this treatment. Using a stamping technique, the neuromodulator and hyaluronic acid filler mixture in the AQUAGOLD® fine touch™ device is pumped into the dermal and epidermal layers of facial skin. Since the muscles are not affected, full movement of the face remains," states Dr. Buckley. AQUAGOLD® fine touch™ is a patented, microchannel microinjector designed to painlessly and effectively deliver microdoses of therapeutics into the skin which makes it the ideal delivery system for 'Skin Botox'. With the AQUAGOLD® fine touch™ we deliver hundreds of microdoses in a single session compared to the handful of times Botox is traditionally injected into facial muscles.

Similar to traditional Botox injections, the results can be seen about two weeks following the treatment and last for three to six months. Men and women who are interested in reducing pore size, decreasing facial oil production and fine facial lines are great candidate for 'Skin Botox' using neuromodulators and hyaluronic sugar.

"In addition to creating a smooth, airbrushed look, 'Skin Botox' is also helpful with improving scars," says Dr. Buckley. "In fact, it's a good substance to inject at the end of a surgical procedure to minimize the scar formation following surgery. It can also be used to improve the look of acne scars, such as depressed ice-pick scars. Microtox can be used to help raise these scars from their depths and to make them more level with the rest of the facial skin. Then they are treated again with Microtox to help them blend in with the rest of the facial skin. According to a study published in Plastic and Reconstructive Surgery, Botox injections reduced both the bumpiness and the width of acne scars.

"No matter what cosmetic procedure is being done, at MilfordMD the goal is to always provide ultra-natural looking results. With 'Skin Botox' patients are able to get just that. The treatment creates an airbrushed, smooth, brighter look where the patients simply looks like an improved version of themselves," says Dr. Buckley.

About MilfordMD Cosmetic Dermatology Surgery & Laser Center:

The MilfordMD Cosmetic Dermatology Surgery & Laser Center offers state-of-the-art highly specialized procedures in laser and cosmetic surgery and aesthetic skin care. In addition to its AAAHC nationally accredited surgical center and extensive laser surgery capabilities, MilfordMD offers physician designed skin care products for home use. Milford Pennsylvania's MilfordMD Cosmetic Dermatology Surgery & Laser Center is sought out by patients from around the world for expertise and innovation in cosmetic treatments performed by Board Certified Physicians, Richard E. Buckley, M.D. and Marina Buckley, M.D.

MilfordMD Cosmetic Dermatology Surgery & Laser Center is located at 303 W. Harford Street, Milford, PA 18337. Tel: (570) 491-1962. For real patient video testimonials, follow MilfordMD on Instagram and Facebook, and visit our MilfordMD YouTube channel.

SOURCE MilfordMD Cosmetic Dermatology Surgery & Laser Center

Related Links

https://MilfordMD.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.